Drug Safety Warnings and Updates: July-September 2017

Teresa Rubio, PharmD

Disclosures

January 03, 2018

Editorial Collaboration

Medscape &

In This Article

Cabazitaxel (JEVTANA® kit)

For more on this Drug Safety Labeling Change, click here.

For full prescribing information, click here.

Updated Boxed Warning

WARNING: NEUTROPENIA AND HYPERSENSITIVITY

Neutropenia

  • Neutropenic deaths have been reported. Monitor for neutropenia with frequent blood cell counts. JEVTANA is contraindicated in patients with neutrophil counts of less than or equal to 1500 cells/mm3. Primary prophylaxis with G-CSF is recommended in patients with high-risk clinical features.

Comments

3090D553-9492-4563-8681-AD288FA52ACE

processing....